Mauritania

in page functions
[French]
Mauritania
Total population (2018) 4,367,530
Birth cohort (2018) 139,321
Surviving Infants (surviving to 1 year per year, 2018) 130,683
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 65/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 85/1000
World Bank Index, IDA (2015) 3.32
Gross Nation Income (per capita US$, 2014) 1,370
Co-financing group (2018) Preparatory transition
No. of districts/territories (2017) 55

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Mauritania

Type of support

Approvals

2001-2022 (US$)
(22 Jun 2018)

Commitments

2001-2022 (US$)
(22 Jun 2018)

Disbursements

2000-2018 (US$)
(22 Jun 2018)

% Disbursed

(22 Jun 2018)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $32,041,690 $38,746,696 $33,141,865
Cold Chain Equipment Optimisation Platform (CCEOP) $595,384 $595,384
Health system strengthening (HSS 1) $2,384,585 $2,384,585 $2,376,428 100%
Health system strengthening (HSS 2) $1,388,292 $3,463,798 $1,388,292 100%
HepB mono (NVS) $631,309 $631,309 $631,309 100%
Immunisation services support (ISS) $735,361 $735,361 $735,361 100%
Injection Safety Devices (NVS) $164,000 $245,500 $220,085 134%
Injection safety support (INS) $205,000 $205,000 $205,000 100%
IPV (NVS) $445,606 $445,606 $362,558 81%
Meningitis A - campaign (NVS) $1,227,500 $1,227,500 $1,236,114 101%
Meningitis A - operational costs (OPC) $1,005,500 $1,005,500 $1,005,500 100%
MR 1st dose (NVS) $70,000 $183,500 $70,660 101%
MR-Catch-up campaign (NVS) $1,222,000 $1,222,000 $1,224,721 100%
MR-Catch-up campaign op.costs (OPC) $889,246 $889,246 $889,246 100%
Penta (NVS) $8,427,610 $8,983,610 $8,584,989 102%
Pneumo (NVS) $9,598,417 $12,455,917 $11,016,395 115%
Product Switch Grant (PSG) $36,811 $36,811 $36,811 100%
Rotavirus (NVS) $2,361,298 $3,382,298 $2,504,626 106%
Vaccine Introduction Grant (VIG) $653,771 $653,771 $653,770 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mauritania DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2010) 61.10%
Household survey: DTP3 coverage for female (2010) 59.20%
Household survey: Last DTP3 survey (2010) 60%
% districts achieving > 80% DTP3 coverage (2017) 76%
% districts achieving < 50% DTP3 coverage (2017) 2%
MCV WHO/UNICEF estimates (2016) 70%

Breakdown of support

Non-vaccine support Vaccine support
22% 78%
$7,290,408 $25,851,457

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mauritania

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

25 June 2015

Dr Seth Berkley, CEO of Gavi; Bill Gates Co-Chair of the Bill & Melinda Gates, Laurent Fabius, Minister of Foreign Affairs and International Development, Jean-Marc Gravellini, Executive Director in charge of Operations of the AFD.

Health in the Sahel region, together to improve immunisation programmes

The AFD, the Bill and Melinda Gates Foundation and Gavi signed an Initiative to increase coverage rates in six Sahel countries.

close icon

modal window here